Aurora Cannabis (NASDAQ:ACB - Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Parties that wish to register for the company's conference call can do so using this link.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.24. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. The business had revenue of $67.27 million for the quarter, compared to analysts' expectations of $55.98 million. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Aurora Cannabis Stock Down 3.7 %
Shares of NASDAQ ACB traded down $0.22 during mid-day trading on Wednesday, reaching $5.68. The company had a trading volume of 715,159 shares, compared to its average volume of 3,135,889. The stock has a market capitalization of $309.82 million, a PE ratio of -4.06 and a beta of 1.86. Aurora Cannabis has a twelve month low of $2.84 and a twelve month high of $9.35. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.03 and a current ratio of 3.76. The stock's 50 day moving average is $5.74 and its 200-day moving average is $6.02.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
